In this study, we demonstrated that the knockdown of PTX3 suppressed the metastatic ability of cervical cancer cells, which is consistent with the previous notion that PTX3 is a potential therapeutic target for head and neck cancer17. This evidence concerns the gene PTX3 and cervical cancer.